Title: | Synergistic Composition for Drug Sensitization and Therapy in Cancer |
Area: | Medical Sciences |
Focus Area: | Cancer Treatment |
Patent: | US8012952, US9364566, US9861653, |
Social Benefits: | A glucocorticoid receptor (GR)-based platform technology: carries multiple drugs induces targeted drug sensitization, EMT-reversal and kills drug- resistant cancer cells and cancer stem cells (CSCs); hence, suited to also treat cancer relapse. The technology repurposes a typical cancer drugs against multiple cancers |
Developing Agency: | CSIR-Indian Institute of Chemical Technology (IICT), Telangana |
Technology Readiness Index: | Technology Development |
Email: | director@iict.res.in |
| Website Link : | http://www.iictindia.org |
| Source (more info) : | https://t.ly/l_sb |